Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.

Osaki A, Shimoda Y, Okada J, Yamada E, Saito T, Nakajima Y, Ozawa A, Niijima Y, Okada S, Yamada M

Open source

DOI
10.1007/s13300-019-0649-8
Published
2019 Aug
Container
Diabetes therapy : research, treatment and education of diabetes and related disorders
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s13300-019-0649-8,
  title = {Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.},
  author = {Osaki A and Shimoda Y and Okada J and Yamada E and Saito T and Nakajima Y and Ozawa A and Niijima Y and Okada S and Yamada M},
  year = {2019},
  journal = {Diabetes therapy : research, treatment and education of diabetes and related disorders},
  doi = {10.1007/s13300-019-0649-8},
  url = {https://doi.org/10.1007/s13300-019-0649-8}
}

RIS

TY  - JOUR
TI  - Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.
AU  - Osaki A
AU  - Shimoda Y
AU  - Okada J
AU  - Yamada E
AU  - Saito T
AU  - Nakajima Y
AU  - Ozawa A
AU  - Niijima Y
AU  - Okada S
AU  - Yamada M
PY  - 2019
JO  - Diabetes therapy : research, treatment and education of diabetes and related disorders
DO  - 10.1007/s13300-019-0649-8
UR  - https://doi.org/10.1007/s13300-019-0649-8
ER  - 

APA

A, O., Y, S., J, O., E, Y., T, S., Y, N., A, O., Y, N., S, O., & M, Y. (2019). Lower Renal Threshold for Glucose Reabsorption in Type 1 Diabetes Mellitus (T1DM) May Explain the Smaller Contribution of SGLT2 Inhibitors to the Improvement of Plasma Glucose Control Compared with T2DM.. Diabetes therapy : research, treatment and education of diabetes and related disorders. https://doi.org/10.1007/s13300-019-0649-8

Source records